Home › Sclerosing Cholangitis
Sclerosing Cholangitis clinical trials recruiting in the U.S.
17 studies for Sclerosing Cholangitis are recruiting participants at sites across the United States.
Cities with the most studies
- Cincinnati, OH4 studies
- Seattle, WA4 studies
- Rochester, MN4 studies
- Mountain View, CA3 studies
- Aurora, CO3 studies
- Sacramento, CA3 studies
By state
- California7 studies
- Colorado3 studies
- Maryland3 studies
- Minnesota5 studies
- Ohio5 studies
- Pennsylvania3 studies
- Texas3 studies
- Utah3 studies
- Washington4 studies
Recently updated studies
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07387549Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT04685200A-LiNK: Improving Outcomes in Autoimmune Liver Disease
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
RecruitingObservational study
Ages 6 to 23 · All sexes · Updated Aug 19, 2026 · NCT03178630MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
RecruitingObservational study
Ages 6 to 23 · All sexes · Updated Aug 19, 2026 · NCT03175471Detoxification of the Liver In PSC (Dolphin)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 21, 2026 · NCT05835505Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 17, 2026 · NCT06905054Primary Sclerosing Cholangitis in Children
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
RecruitingEarly phase 1
Ages 18 to 76 · All sexes · Updated May 20, 2026 · NCT06197308A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 68 · All sexes · Updated Mar 5, 2026 · NCT07229911Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Feb 27, 2026 · NCT05912387Biobank for Cholestatic Liver Diseases.
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Feb 17, 2026 · NCT03445585Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Feb 17, 2026 · NCT04753996A Study of SIPLIZUMAB in AILD and LT Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT06455280A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 24, 2025 · NCT06699121Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
RecruitingPhase 2
Ages 14 to 75 · All sexes · Updated Jun 13, 2025 · NCT05295680Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RecruitingPhase 1Healthy volunteers welcome
2 Weeks – 40 Years · All sexes · Updated Nov 15, 2016 · NCT02137668From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.